Bulletin from the Annual General Meeting of Asarina Pharma AB (publ)
The following resolutions were passed at the annual general meeting (the “AGM”) of Asarina Pharma AB (publ) (“Asarina Pharma”) on 21 April 2021 in Stockholm. The CEO’s presentation is available at the company’s website.Adoption of income statement and balance sheet and discharge from liability The AGM resolved to adopt the income statement for the financial year 2020 as well as the balance sheet and consolidated balance sheet as of 31 December 2020. The members of the Board of Directors and the managing director were discharged from liability for the financial year 2020. Allocation of